Submitted:
10 June 2025
Posted:
12 June 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. How the Center Works
2.2. Inclusion and Exclusion Criteria for the Study
2.3. Data Preparation for the Analysis Process
Statistical Analysis
Results
4. Discussion
Limitations
5. Conclusions
Author Contributions
Funding (publication fee)
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Ha, S.-Y.; Sung, Y.-H. Changes of neural pathways after Vojta approach in a child with developmental delay. Children 2021, 8, 918. [Google Scholar] [CrossRef] [PubMed]
- Banaszek, G. Vojta’s method as the early neuro developmenetal diagnostic and therapy concept. Przegl Lek 2010, 67, 67–76. [Google Scholar] [PubMed]
- Duncan, G.J.; Lee, K.T.H.; Rosales-Rueda, M.; Kalil, A. Maternal Age and Child Development. Demography 2018, 55, 2229–2255. [Google Scholar] [CrossRef] [PubMed]
- Oña Oña, M.N.; Cofre Chango, M.X.; Rivera Aguiler, T.E.; Arévalo Pacheco, M.J.; Heredia Nugra, S.M. Alterations in neurodevelopment and brain damage in neonates. Sapienza: Int J Interdisc Studies. 2024, 5. [Google Scholar] [CrossRef]
- Boutsikou, T.A.; Malamitsi-Puchner, A. Caesarean section: Impact on mother and child. Acta Paedriatr 2011, 100, 1518–1522. [Google Scholar] [CrossRef]
- Oddy, W.; Robinson, M.; Kendall, G.; Li, J.; Zubrick, S.R.; Stanley, F.J. Breastfeeding and early child development: A prospective cohort study. Acta Peadiatr 2011, 100, 992–999. [Google Scholar] [CrossRef]
- Dan, B. Sex differences in neurodevelopmental disorders. Dev Med Child Neurol 2021, 63, 492. [Google Scholar] [CrossRef]
- You, J.; Shamsi, B.H.; Hao, M.; Cao, C.H.; Yang, W.Y. A study on the neurodevelopment outcomes of late preterm infants. BMC Neurology 2019, 19. [Google Scholar] [CrossRef]
- Yamada, T.; Akaishi, R.; Yamada, T.; Morikawa, M.; Kaneuchi, M.; Minakami, H. Risk of cerebral palsy associated with neonatal encephalopathy in macrosomic neonates. J Obstet Gynaecol Res 2014, 40, 1611–1617. [Google Scholar] [CrossRef]
- Ehrenstein, V. Association of Apgar scores with death and neurologic disability. Clin Epidemiol 2009, 9, 45–53. [Google Scholar] [CrossRef]
- Zhang, M.; Gazimbi, M.; Chen, Z.; Zhang, B.; Chen, Y.; Yu, Y.; et al. Association between birth weight and neurodevelopment at age 1–6 months: Results from the Wuhan Healthy Baby Cohort. BMJ Open 2020, 10, e031916. [Google Scholar] [CrossRef] [PubMed]
- Andrzejewska, M.; Hap, K.; Biernat, K.; Sutkowska, E.; Demczyszak, I.; Marciniak, D.; et al. Factors affecting rehabilitation of infants with Central Coordination Disorders during a three-month-long observation. BMC Pediatr 2021, 21, 579. [Google Scholar] [CrossRef] [PubMed]
- Jain, A.; Veerabhadrappe, H.; Shrikent, S.W.; Kumari, N. Better prediction of neurodevelopment outcome in babies using combined Vojta’s neurokinesiological examination, Aniel Tison Angels and Head Holding Grades. J Nepal Paediatr Soc. 2021, 41. [Google Scholar] [CrossRef]
- Khan, M.H.; Grzegorzek, M. Vojta therapy: A vision based framework to recognize movement patterns. Int J Soft Inn 2017, 3, 18–32. [Google Scholar] [CrossRef]
- Gomez-Conesa, A.; Fernández Rego, F.J.; Agüera Arenas, J.J. Vojta therapy in the reduction of perinatal risk in preterm infants with respiratory distress syndrome and bronchopulmonary dysplasia. Physiother 2016, 102, 199. [Google Scholar] [CrossRef]
- Juan Luis, S. Critical review of the evidence for Vojta therapy: A systematic review and meta-analysis. Front Neurol 2024, 15, 1391448. [Google Scholar] [CrossRef]
- Jäkel, A.; von Hauenschild, P. Therapeutic effects of cranial osteopathic manipulative medicine: A systematic review. J Am Osteopath Assoc 2011, 111, 685–693. [Google Scholar]
- Amendolara, A.; Sheppert, A.; Powers, R.; Payne, A.; Stacey, S.; Sant, D. Effectiveness of osteopathic craniosacral techniques: A meta-analysis. Front Med. 2024, 11, 1452465. [Google Scholar] [CrossRef]
- Ceballos-Leita, L.; Ernst, E.; Carrasco-Uribarren, A.; Cabanillas-Barea, S.; Esteban-Perez, J.; Jimenez-del-Barrio, S. Is craniosacral therapy effective? A systematic review and meta-analysis. Healthcare 2024, 12, 679. [Google Scholar] [CrossRef]
- Castejón-Castejón, M.; Murcia-González, M.A.; Martínez Gil, J.L.; Todri, J.; Suarez Rancel, M.; Lena, O.; et al. Effectiveness of craniosacral therapy in the treatment of infantile colic. A randomized controlled trial. Complement Ther Med 2019, 47, 102164. [Google Scholar] [CrossRef]
- Haller, H.; Lauche, R.; Sundberg, T.; Dobos, G.; Cramer, H. Craniosacral therapy for chronic pain: A systematic review and metaanalysis of randomized controlled trials. BMC Musculoskeletal Disord 2020, 21, 1. [Google Scholar] [CrossRef] [PubMed]
- Kratz, S.V.; Kerr, J.; Porter, L. The use of CranioSacral therapy for Autism Spectrum Disorders: Benefits from the viewpoints of parents, clients, and therapists. J Bodyw Mov Ther 2017, 21, 19–29. [Google Scholar] [CrossRef] [PubMed]
- Raith, W.; Marschik, P.B.; Sommer, C.; Maurer-Fellbaum, U.; Amhofer, C.; Avian, A.; et al. General movements in preterm infants undergoing craniosacral therapy: A randomized controlled pilot trials. BMC Compl Alter Med 2016, 16, 12. [Google Scholar] [CrossRef] [PubMed]
- Amrovabady, Z.S.; Esteki, M.; Pishyareh, E.; Haghgoo, H. Effect of Craniosacral Therapy on Students' Symptoms of Attention Deficit Hyperactivity Disorder. Iranian Rehabilitation Journal. 2013, 11, 27–33. [Google Scholar]
- Muñoz-Gómez, E.; Inglés, M.; Aguilar-Rodríguez, M.; Mollà-Casanova, S.; Sempere-Rubio, N.; Serra-Añó, P.; Espí-López, G.V. Effect of a Craniosacral Therapy Protocol in People with Migraine: A Randomized Controlled Trial. J Clin Med 2022, 11, 759. [Google Scholar] [CrossRef]
- Leon-Bravo, G.; Cantarero-Carmona, I.A. Longitudinal, Observational, and Descriptive Study About Benefits of Craniosacral Therapy in Child Neurodevelopment. Clin Pediatr 2025, 64, 25–35. [Google Scholar] [CrossRef]
- Opavsky, J.; Slachtova, M.; Kutin, M.; Hok, P.; Uhlir, P.; Opavska, A.; et al. The effects of sustained manual pressure stimulation according to Vojta Therapy on heart rate variability. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018, 162, 206–211. [Google Scholar] [CrossRef]
- Martínek, M.; Pánek, D.; Nováková, T.; Pavl, D. Analysis of Intracerebral Activity during Reflex Locomotion Stimulation According to Vojta’s Principle. Appl. Sci 2022, 12, 2225. [Google Scholar] [CrossRef]
- Kiebzak, W.; Zurawski, A.; Gluszek, S.; Kosztolowicz, M.; Bialek, W.A. Cortisol levels in infants with central coordination disorders during VOJTA therapy. Children 2021, 8, 1113. [Google Scholar] [CrossRef]
- Cook, A.C.; Egli, A.E.; Cohen, N.E.; Bernardi, K.; Chae, M.Y.; Kapalko, B.A.; Coyne, S.A.; Scott, R. The Neurophysiological Effects of Craniosacral Treatment on Heart Rate Variability: A Systematic Review of Literature and Meta-Analysis. Cureus. 2024, 16, e64807. [Google Scholar] [CrossRef]
- Wójcik, M.; Bordoni, B.; Siatkowski, I.; Żekanowska, E. The Effect of Craniosacral Therapy on Blood Levels of Stress Hormones in Male Firefighter Cadets: A Randomized Clinical Trial. Behav Sci 2023, 13. [Google Scholar] [CrossRef] [PubMed]

|
Variable |
Vojta therapy | Vojta therapy + craniosacral therapy | Student’s t-test | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shapiro-Wilk test p ≥ 0.05 | |||||||||||
| N | Mean | -95% CI |
+95% CI | SD± | N | Mean | -95% CI |
+95% CI | SD± | p | |
| mother's age at the time of delivery (years) |
32 |
31.19 |
29.33 |
33.04 |
5.15 |
19 |
29.84 |
27.35 |
32.33 |
5.17 |
0.3718 |
| birth weight (gram) |
32 |
3,191.56 | 3,020.82 | 3,362.31 | 473.59 | 19 | 3,207.63 | 2,894.17 | 3,521.09 | 650.36 |
0.9194 |
|
Variable |
Shapiro-Wilk test p < 0.05 |
Mann-Whitney U test |
|||||||||
| N | Median | Min | Max | N | Median | Min | Max | p | |||
| duration of breastfeeding (weeks) |
32 |
11.5 |
0.0 |
43.0 |
19 |
15.0 |
1.0 |
47.0 |
0.5787 |
||
| APGAR score | 32 | 10.0 | 8.0 | 10.0 | 19 | 10.0 | 8.0 | 10.0 | 0.2585 | ||
| gestational week at birth (week) |
32 |
39.0 |
34.0 |
41.0 |
19 |
39.0 |
31.0 |
41.0 |
0.9922 |
||
| age of the child at the start of therapy (weeks) |
32 |
3.0 |
1.0 |
5.0 |
19 |
3.0 |
1.0 |
4.0 |
0.1336 |
||
|
Vojta therapy n=32; 62,75% |
Vojta therapy plus craniosacral therapy n=19; 37.25% |
Chi2-test |
|||
|---|---|---|---|---|---|
| Follow-up visit No improvement n (% of total N) |
Follow-up visit Improvement n (% of total N) |
Follow-up visit No improvement n (% of total N) |
Follow-up visit Improvement n (% of total N) |
statistics df |
p |
| 11 (21.57) | 21 (41.18) | 1 (1.96) | 18 (35.29) | 5.615; df=1 | 0.01781 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).